Dr. Rebecca Elstrom Discusses Indolent Lymphoma

Weill Cornell’s Rebecca Elstrom, MD was interviewed for the Lymphoma Foundation of America’s Lymphoma Help webcast series. Dr. Elstrom discussed Indolent Lymphomas. Click the player below to listen to the discussion with Dr. Elstrom.

Phase I trial of anti-CD74 (hLL1) Antibody Therapy in B-cell malignancies

Update: this study is closed to enrollment. 

Previous expericence with antibody therapy in both non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) suggests the need for further exploration of new antibody treatments for these diseases.

This is a Phase I, open-label study being conducted in patients with recurrent non-Hodgkin’s lymphoma or chronic lymphocytic leukemia who have progressed after at least one prior standard treatment.

Click here to for the clinical and research profile of John Leonard, MD, the physician leading the study.

Weill Cornell’s Dr. Ruben Niesvizky and Dr. Ellen Ritchie Raising Funds for LLS Man/Woman of the Year

Drs. Ellen Ritchie and Ruben Niesvizky are campaigning for the Leukemia and Lymphoma Society’s (LLS) Woman and Man of the Year awards. The campaign is a 10-week competition to raise at least $20,000 each in honor of four local pediatric cancer patients. The candidates who raise the most money will be awarded the titles. The money raised in this campaign provides funds for LLS education and support services for patients and their families as well as cancer research.

Please help raise funds for Ellen and Ruben between now and May 19. Click here for Dr. Ritchie’s fundraising page. Click here for Dr. Niesvizky’s fundraising page.